W. Fan

发表

Declining hepatitis C rates in first‐time blood donors: insight from surveillance and case‐control risk factor studies

C. Infante-Rivard, J. Chiavetta, M. Fearon, 2008, Transfusion.

Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt‐Jakob disease deferral policies

E. Vamvakas, J. Chiavetta, S. O’Brien, 2006, Transfusion.

Reassessment of deferrals for tattooing and piercing

S. O’Brien, M. Goldman, Q. Yi, 2009, Transfusion.

Prevalence and Estimated Incidence of Blood‐Borne Viral Pathogen Infection in Organ and Tissue Donors from Northern Alberta

J. Preiksaitis, S. Plitt, S. O’Brien, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer “no” to risk questions

M. Ndao, M. Fearon, S. O’Brien, 2014, Transfusion.

Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services

M. Ndao, M. Fearon, S. O’Brien, 2013, Transfusion.

Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing

J. Chiavetta, M. Fearon, S. O’Brien, 2008, Transfusion.

Face‐to‐face interviewing in predonation screening: lack of effect on detected human immunodeficiency virus and hepatitis C virus infections

E. Vamvakas, J. Chiavetta, S. O’Brien, 2006, Transfusion.

Compliance with time‐based deferrals for men who have sex with men

S. O’Brien, M. Goldman, Q. Yi, 2019, Transfusion.

Epidemiology of hepatitis B in Canadian blood donors

M. Fearon, S. O’Brien, V. Scalia, 2008, Transfusion.

Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience

S. O’Brien, M. Goldman, Q. Yi, 2010, Vox sanguinis.

Hepatitis B virus DNA–positive, hepatitis B surface antigen–negative blood donations intercepted by anti‐hepatitis B core antigen testing: the Canadian Blood Services experience

E. Vamvakas, M. Fearon, S. O’Brien, 2007, Transfusion.

Residual risk of HIV, HCV and HBV in Canada.

M. Fearon, S. O’Brien, V. Scalia, 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

The impact of increasing the upper age limit of donation on the eligible blood donor population in Canada

M. Germain, S. O’Brien, M. Goldman, 2012, Transfusion medicine.

Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services

S. Kleinman, E. Vamvakas, S. O’Brien, 2007, Transfusion.

Impact of a 5‐year deferral from blood donation for men who have sex with men

S. O’Brien, M. Goldman, Q. Yi, 2016, Transfusion.

Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services

J. Allain, M. Fearon, S. O’Brien, 2012, Vox sanguinis.

HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada

S. O’Brien, M. Goldman, Q. Yi, 2021, Transfusion.

Detection of hepatitis C virus and human immunodeficiency virus‐1 antibody‐negative donations: Canadian Blood Services’ experience with nucleic acid testing

S. O’Brien, V. Scalia, M. Goldman, 2006, Vox Sanguinis.

The epidemiology of human T‐cell lymphotropic virus types I and II in Canadian blood donors

S. O’Brien, V. Scalia, M. Goldman, 2013, Transfusion medicine.

Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services

M. Ndao, M. Fearon, S. O’Brien, 2013, Transfusion.

Declining hepatitis C rates in first‐time blood donors: insight from surveillance and case‐control risk factor studies

C. Infante-Rivard, J. Chiavetta, M. Fearon, 2008, Transfusion.